Stimulating the Immune System With Coxsackievirus in Advanced Cancer Patients

May 27, 2017

Charles M. Rudin, MD, PhD, chief, thoracic oncology, Memorial Sloan Kettering Cancer, discusses a study of intravenously delivered coxsackievirus A21 with pembrolizumab to treat patients with advanced cancers.